Form 4: Encompass Health Director Greg D. Carmichael Reports Changes in Beneficial Ownership

Director Greg D. Carmichael reports dividend reinvestments and restricted stock unit awards, increasing his holdings in Encompass Health common stock.

Summary

• Greg D. Carmichael, a director of Encompass Health Corp, filed a Form 4 detailing changes in his beneficial ownership of the company's common stock.
• The reported transactions include dividend reinvestments on January 16, 2024, April 15, 2024, and July 15, 2024, at prices of $68.64, $81.47, and $86.89 per share, respectively.
• Additionally, on October 15, 2024, Carmichael received 24 restricted stock units (RSUs) due to a common stock dividend payment, with the closing price on that date being $96.33.
• Following these transactions, Carmichael's direct ownership increased to 17,112 shares of Encompass Health common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The director is increasing his stake, which could be interpreted as a positive signal, but the transactions are routine and expected.

Positives

• The director is increasing his stake in the company through dividend reinvestments and RSU awards, which could signal confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't provide specific insights into broader industry trends. However, director's increased stake could be seen as a positive sign.

Stakeholder Impact

• The increased holdings by a director could be viewed positively by shareholders.

Key Dates